Herpes zoster dendritic keratitis.
D000328:Adult; D000368:Aged; D002478:Cells, Cultured; D003315:Cornea / Q000382:microbiology; D003588:Cytopathogenic Effect, Viral; D003907:Dexamethasone / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D006563:Herpes Zoster Ophthalmicus / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D014645:Herpesvirus 3, Human / Q000302:isolation & purification; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007500:Iritis / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D007635:Keratitis, Dendritic / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D007945:Leukemia, Lymphoid / Q000150:complications; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012867:Skin / Q000382:microbiology
D004917:Erythromycin; D003907:Dexamethasone; D007065:Idoxuridine; D011241:Prednisone